Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Sokol

Showing results (191-200 of 267) with videos related to

Pageof 27
Sort By:
Nature Cancer|April 9, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysisSophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 9, 2024
Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trialGaston H Rueda, Natalia Causada-Calo, Rajka Borojevic, et al.
Gastro Hep Advances|February 17, 2022
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 InfectionPauline Maisonnasse, Thierry Poynard, Mehdi Sakka, et al.
Gut Microbes|June 22, 2026
Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation by <i>Sutterella</i> speciesLouise Dupraz, Giovanna Orianne, Grégory Da Costa, et al.
Alimentary Pharmacology & Therapeutics|October 10, 2024
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National SurveyNicolas Benech, Nadim Cassir, Laurent Alric, et al.
Cell Reports|October 28, 2023
An obesogenic diet increases atherosclerosis through promoting microbiota dysbiosis-induced gut lymphocyte trafficking into the peripheryLudivine Laurans, Nirmala Mouttoulingam, Mouna Chajadine, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Trials|June 5, 2020
Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trialCaroline Trang-Poisson, Elise Kerdreux, Alexandra Poinas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2023
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trialPhilippe Merle, Jean-Frédéric Blanc, Julien Edeline, et al.
Gut Microbes|May 31, 2022
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancerAonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, et al.
Pageof 27

Showing results (191-200 of 267) with videos related to

Sort By:
Pageof 27
Nature Cancer|April 9, 2025
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysisSophie Cousin, Jean-Philippe Guégan, Lola Jade Palmieri, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|April 9, 2024
Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trialGaston H Rueda, Natalia Causada-Calo, Rajka Borojevic, et al.
Gastro Hep Advances|February 17, 2022
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 InfectionPauline Maisonnasse, Thierry Poynard, Mehdi Sakka, et al.
Gut Microbes|June 22, 2026
Inhibition of Aryl hydrocarbon receptor Interleukin-22 signaling and worsening of intestinal inflammation by <i>Sutterella</i> speciesLouise Dupraz, Giovanna Orianne, Grégory Da Costa, et al.
Alimentary Pharmacology & Therapeutics|October 10, 2024
Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5-Year French National SurveyNicolas Benech, Nadim Cassir, Laurent Alric, et al.
Cell Reports|October 28, 2023
An obesogenic diet increases atherosclerosis through promoting microbiota dysbiosis-induced gut lymphocyte trafficking into the peripheryLudivine Laurans, Nirmala Mouttoulingam, Mouna Chajadine, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Trials|June 5, 2020
Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trialCaroline Trang-Poisson, Elise Kerdreux, Alexandra Poinas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2023
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trialPhilippe Merle, Jean-Frédéric Blanc, Julien Edeline, et al.
Gut Microbes|May 31, 2022
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancerAonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, et al.
Pageof 27